1158 related articles for article (PubMed ID: 7655867)
1. Raynaud's phenomenon in systemic lupus erythematosus.
Lavras Costallat LT; Valente Coimbra AM
Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
[TBL] [Abstract][Full Text] [Related]
2. Alopecia in systemic lupus erythematosus. Relation to disease manifestations.
Wysenbeek AJ; Leibovici L; Amit M; Weinberger A
J Rheumatol; 1991 Aug; 18(8):1185-6. PubMed ID: 1941821
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
5. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
[TBL] [Abstract][Full Text] [Related]
6. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.
Marini R; Costallat LT
Rev Rhum Engl Ed; 1999 Jun; 66(6):303-9. PubMed ID: 10418057
[TBL] [Abstract][Full Text] [Related]
7. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
Li EK; Tam LS
J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670
[TBL] [Abstract][Full Text] [Related]
9. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
Mikulska D
Ann Acad Med Stetin; 2009; 55(3):23-7. PubMed ID: 20698174
[TBL] [Abstract][Full Text] [Related]
12. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
[TBL] [Abstract][Full Text] [Related]
14. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of systemic lupus erythematosus with gastrointestinal manifestations.
Xu D; Yang H; Lai CC; Li P; Zhang X; Yang XO; Zhang FC; Qian JM
Lupus; 2010 Jun; 19(7):866-9. PubMed ID: 20410154
[TBL] [Abstract][Full Text] [Related]
16. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus.
Richter JG; Sander O; Schneider M; Klein-Weigel P
Lupus; 2010 Aug; 19(9):1087-95. PubMed ID: 20693202
[TBL] [Abstract][Full Text] [Related]
18. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
19. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
